Table 1 Properties of carbapenem-resistant A. baumannii (CRAB) isolates recovered from COVID-19 patients admitted to an Iranian referral hospital at the first wave of COVID-19
COVID-19 patient | Date | Gender | Age (years) | Ward | Length of stay at ICU (days) | Mechanical ventilation | Intubation | Underlying disease | Site | Antibiotic treatment | Outcome | Isolate | oxa genesa | blaTEM | blaNDM-1 | ST |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient 1 | Apr 1, 2020 | Male | 75 | ICU1 | 1 | Yes | Yes | No | Blood | Meropenem, amikacin, ciprofloxacin, linezolid and sulfamethoxazole | Death | AB7 | 23 and 24 | + | − | 2 |
Patient 2 | Apr1, 2020 | Male | 67 | ICU2 | 12 | Yes | Yes | Cardiovascular disease | Blood | Meropenem and colistin | Survive | AB8 | 23 | − | − | 2 |
Patient 3 | Apr4, 2020 | Male | 85 | ICU3 | 31 | Yes | Yes | Hypertension, cardiovascular disease, tracheostomy | Tracheal discharge | Imipenem | Death | AB12 | 23 | − | − | 2 |
Patient 4 | Apr3, 2020 | Male | 46 | ICU3 | 4 | No | No | Hypertension and chronic neuromuscular diseases | Blood | Vancomycin, | Survive | AB14 | 23 and 24 | + | − | 2 |
Patient 5 | Apr3, 2020 | Male | 57 | ICU4 | 28 | Yes | Yes | Asthma | Blood | Imipenem and linezolid | Survive | AB16 | 23 and 24 | + | − | 2 |
Patient 6 | Apr 4,2020 | Male | 60 | ICU5 | 15 | Yes | Yes | Hypertension, cardiovascular disease and mitral valve replacement | Blood | Meropenem | Death | AB18 | 23 | − | − | 2 |
Patient 7 | Apr 8,2020 | Female | 48 | ICU2 | 11 | Yes | Yes | Lymphoma and history of chemotherapy | Tracheal discharge | Levofloxacin and azithromycin | Survive | AB25 | 23 | − | − | 2 |
Patient 8 | Apr 8, 2020 | Female | 63 | ICU5 | 29 | Yes | Yes | Osteoporosis and tracheostomy | Tracheal discharge | Imipenem, colistin, ampicillin/sulbactam and piperacillin/tazobactam | Survive | AB26 | 23 and 24 | − | − | 2 |
Patient 9 | Apr 10, 2020 | Male | 62 | ICU2 | 4 | Yes | Yes | Asthma, cardiovascular diseases and respiratory disease | Tracheal discharge | Azithromycin | Death | AB27 | 23 and 24 | − | − | 2 |
Patient 10 | Apr 12, 2020 | Male | 39 | ICU3 | 18 | Yes | Yes | No | Tracheal discharge | Meropenem, colistin and vancomycin | Death | AB29 | 23 | − | − | 2 |
Patient 11 | Apr 13, 2020 | Male | 87 | ICU5 | 17 | Yes | Yes | Asthma | Tracheal discharge | Piperacillin/tazobactam, vancomycin, meropenem, colistin, amikacin, gentamicin, ciprofloxacin, sulfamethoxazole, ceftriaxone, ceftazidim | Death | AB35 | 23 | − | − | 2 |
Patient 12 | Apr 15, 2020 | Female | 53 | ICU3 | 8 | Yes | Yes | No | Tracheal discharge | No | Death | AB36 | 23 | − | − | 2 |
Patient 13 | Apr 16, 2020 | Female | 73 | ICU5 | 6 | Yes | Yes | Hypothyroidism | Tracheal discharge | Vancomycin, linezloid, meropenem, colistin and levofloxacin | Survive | AB39 | 23 | − | − | 2 |
Patient 14 | Apr 16, 2020 | Female | 71 | ICU5 | 22 | Yes | Yes | Asthma and diabetes | Blood | Colistin, gentamicin and sulfamethoxazole | Death | AB40 | 23 | − | − | 2 |
Patient 15 | Apr 18, 2020 | Male | 66 | ICU4 | 10 | No | No | Necrotizing fasciitis | Tracheal discharge | Meropenem, ciprofloxacin, tazocin, imipenem, sulfamethoxazole | Survive | AB41 | 23 | − | − | 2 |
Patient 16 | Apr 18, 2020 | Male | 74 | ICU5 | 11 | Yes | Yes | Diabetes | Blood | Meropenem, colistin, piperacillin/tazobactam and gentamicin | Death | AB44 | 23 | − | − | 2 |
Patient 17 | Apr 25, 2020 | Female | 46 | ICU3 | 14 | Yes | Yes | No | Tracheal discharge | Colistin | Death | AB55 | 23 | − | − | 2 |
Patient 18 | Apr 26, 2020 | Male | 79 | ICU2 | 3 | Yes | Yes | Chronic kidney disease | Tracheal discharge | Imipenem,meropnem, colistin | Survive | AB56 | 23 | − | − | 2 |